Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Gastric Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 128 articles:
HTML format



Single Articles


    October 2020
  1. NISHIWAKI N, Irino T, Fujiya K, Kamiya S, et al
    Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer.
    Eur J Surg Oncol. 2020 Oct 23. pii: S0748-7983(20)30860.
    PubMed     Abstract available


  2. GERTSEN EC, Brenkman HJF, Brosens LAA, Luijten JCHBM, et al
    Refraining from resection in patients with potentially curable gastric carcinoma.
    Eur J Surg Oncol. 2020 Oct 22. pii: S0748-7983(20)30862.
    PubMed     Abstract available


  3. BENCIVENGA M, Torroni L, Verlato G, Mengardo V, et al
    Lymphadenectomy for gastric cancer at European specialist centres.
    Eur J Surg Oncol. 2020 Oct 15. pii: S0748-7983(20)30845.
    PubMed     Abstract available


  4. BRANDL A, Yonemura Y, Glehen O, Sugarbaker P, et al
    Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
    Eur J Surg Oncol. 2020 Oct 14. pii: S0748-7983(20)30839.
    PubMed     Abstract available


    August 2020
  5. TU RH, Lin JX, Wang W, Li P, et al
    Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with
    Eur J Surg Oncol. 2020 Aug 10. pii: S0748-7983(20)30574.
    PubMed     Abstract available


  6. KOEMANS WJ, van der Kaaij RT, Wassenaar ECE, Grootscholten C, et al
    Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy.
    Eur J Surg Oncol. 2020 Aug 5. pii: S0748-7983(20)30664.
    PubMed     Abstract available


    July 2020
  7. XU LB, Zhang HH, Shi MM, Huang ZX, et al
    Metabolic syndrome-related sarcopenia is associated with worse prognosis in patients with gastric cancer: A prospective study.
    Eur J Surg Oncol. 2020 Jul 29. pii: S0748-7983(20)30659.
    PubMed     Abstract available


  8. KOTA I, Makoto H, Satoshi K, Yutaka T, et al
    Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer.
    Eur J Surg Oncol. 2020 Jul 27. pii: S0748-7983(20)30658.
    PubMed     Abstract available


  9. CHEN QY, Zhong Q, Liu ZY, Huang XB, et al
    Advances in laparoscopic surgery for the treatment of advanced gastric cancer in China.
    Eur J Surg Oncol. 2020 Jul 17. pii: S0748-7983(20)30641.
    PubMed     Abstract available


  10. FURUKAWA K, Kamiya S, Sugino T, Aizawa D, et al
    Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin.
    Eur J Surg Oncol. 2020 Jul 15. pii: S0748-7983(20)30575.
    PubMed     Abstract available


  11. CHEN X, Feng X, Wang M, Yao X, et al
    Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.
    Eur J Surg Oncol. 2020 Jul 11. pii: S0748-7983(20)30572.
    PubMed     Abstract available


  12. TRAPANI R, Rausei S, Reddavid R, Degiuli M, et al
    Risk factors for esophago-jejunal anastomosis leakage after total gastrectomy for cancer. A multicenter retrospective study of the Italian research group for gastric cancer.
    Eur J Surg Oncol. 2020 Jul 9. pii: S0748-7983(20)30560.
    PubMed     Abstract available


  13. WANG P, Deng J, Sun Z, Wang W, et al
    Proposal of a novel subclassification of pN3b for improvement the prognostic discrimination ability of gastric cancer patients.
    Eur J Surg Oncol. 2020 Jul 4. pii: S0748-7983(20)30558.
    PubMed     Abstract available


    June 2020
  14. WANG X, Sun J, Zhang W, Yang X, et al
    Use of radiomics to extract splenic features to predict prognosis of patients with gastric cancer.
    Eur J Surg Oncol. 2020 Jun 27. pii: S0748-7983(20)30545.
    PubMed     Abstract available


  15. ZHU Z, Gong Y, Xu H
    Clinical and pathological staging of gastric cancer: Current perspectives and implications.
    Eur J Surg Oncol. 2020 Jun 24. pii: S0748-7983(20)30526.
    PubMed     Abstract available


  16. GONG Y, Pan S, Wang X, Zhu G, et al
    A novel lymph node staging system for gastric cancer including modified Union for cancer Control/American Joint Committee on cancer and Japanese Gastric Cancer Association criteria.
    Eur J Surg Oncol. 2020 Jun 23. pii: S0748-7983(20)30525.
    PubMed     Abstract available


  17. OH SE, An JY, Choi MG, Lee JH, et al
    Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.
    Eur J Surg Oncol. 2020 Jun 20. pii: S0748-7983(20)30557.
    PubMed     Abstract available


  18. ALYAMI M, Bonnot PE, Mercier F, Laplace N, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Eur J Surg Oncol. 2020 Jun 9. pii: S0748-7983(20)30495.
    PubMed     Abstract available


    May 2020
  19. TEE MC, Pirozzi N, Brahmbhatt RD, Raman S, et al
    Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
    Eur J Surg Oncol. 2020 May 16. pii: S0748-7983(20)30486.
    PubMed     Abstract available


  20. KAMBARA Y, Miyake H, Nagai H, Yoshioka Y, et al
    CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
    Eur J Surg Oncol. 2020 May 16. pii: S0748-7983(20)30456.
    PubMed     Abstract available


  21. SUGAWARA K, Yamashita H, Urabe M, Okumura Y, et al
    Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery.
    Eur J Surg Oncol. 2020 May 4. pii: S0748-7983(20)30441.
    PubMed     Abstract available


    April 2020
  22. HAN WH, Oh YJ, Eom BW, Yoon HM, et al
    Prognostic impact of infectious complications after curative gastric cancer surgery.
    Eur J Surg Oncol. 2020 Apr 23. pii: S0748-7983(20)30429.
    PubMed     Abstract available


  23. KANG JH, Ryu SY, Jung MR, Jeong O, et al
    Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for >/= pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Eur J Surg Oncol. 2020 Apr 14. pii: S0748-7983(20)30410.
    PubMed     Abstract available


  24. GERTSEN EC, de Jongh C, Brenkman HJF, Mertens AC, et al
    The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer.
    Eur J Surg Oncol. 2020 Apr 14. pii: S0748-7983(20)30399.
    PubMed     Abstract available


  25. ARCHID R, Zieker D, Weinreich FJ, Hones F, et al
    shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  26. WANG C, Gao Z, Shen K, Cao J, et al
    Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  27. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
    Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  28. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
    Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


    March 2020
  29. YANG W, Xia F, Wang J, Zhou M, et al
    Quantifying skeletal muscle wasting during chemoradiotherapy with Jacobian calculations for the prediction of survival and toxicity in patients with gastric cancer.
    Eur J Surg Oncol. 2020 Mar 31. pii: S0748-7983(20)30390.
    PubMed     Abstract available


  30. OH SE, An JY, Choi MG, Sohn TS, et al
    Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer.
    Eur J Surg Oncol. 2020 Mar 18. pii: S0748-7983(20)30352.
    PubMed     Abstract available


  31. SATO Y, Mizusawa J, Katayama H, Nakamura K, et al
    Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A.
    Eur J Surg Oncol. 2020 Mar 4. pii: S0748-7983(20)30145.
    PubMed     Abstract available


    January 2020
  32. DIAS AR, Pereira MA, Ramos MFKP, Oliveira RJ, et al
    Prediction scores for complication and recurrence after multivisceral resection in gastric cancer.
    Eur J Surg Oncol. 2020 Jan 11. pii: S0748-7983(20)30018.
    PubMed     Abstract available


  33. LU H, Zhao B, Zhang J, Huang R, et al
    Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30017.
    PubMed     Abstract available


  34. WANG JB, Liu ZY, Huang XB, Chen QY, et al
    Implications for restaging in gastric cancer with peritoneal metastasis based on the 15th Japanese Classification of Gastric Carcinoma: An analysis from a comprehensive center.
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30016.
    PubMed     Abstract available


    December 2019
  35. KARSTENS KF, Ghadban T, Sawez S, Konczalla L, et al
    Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Eur J Surg Oncol. 2019 Dec 14. pii: S0748-7983(19)31504.
    PubMed     Abstract available


    October 2019
  36. PARK SH, Lee S, Song JH, Choi S, et al
    Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.
    Eur J Surg Oncol. 2019 Oct 18. pii: S0748-7983(19)30904.
    PubMed     Abstract available


    September 2019
  37. JEONG SH, Kim RB, Park SY, Park J, et al
    Nomogram for predicting gastric cancer recurrence using biomarker gene expression.
    Eur J Surg Oncol. 2019 Sep 21. pii: S0748-7983(19)30809.
    PubMed     Abstract available


    August 2019
  38. KIM SM, An JY, Byeon SJ, Lee J, et al
    Prognostic value of mismatch repair deficiency in patients with advanced gastric cancer, treated by surgery and adjuvant 5-fluorouracil and leucovorin chemoradiotherapy.
    Eur J Surg Oncol. 2019 Aug 31. pii: S0748-7983(19)30659.
    PubMed     Abstract available


  39. OH Y, Kim MS, Lee YT, Lee CM, et al
    Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2019 Aug 23. pii: S0748-7983(19)30652.
    PubMed     Abstract available


    July 2019
  40. REUTOVICH MY, Krasko OV, Sukonko OG
    Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients.
    Eur J Surg Oncol. 2019 Jul 31. pii: S0748-7983(19)30588.
    PubMed     Abstract available


  41. LIN JX, Huang YQ, Xie JW, Wang JB, et al
    Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
    Eur J Surg Oncol. 2019 Jul 15. pii: S0748-7983(19)30547.
    PubMed     Abstract available


    June 2019
  42. JIN HE, Kim MS, Lee CM, Park JH, et al
    Meta-analysis and systematic review on laparoscopic-assisted distal gastrectomy (LADG) and totally laparoscopic distal gastrectomy (TLDG) for gastric cancer: Preliminary study for a multicenter prospective KLASS07 trial.
    Eur J Surg Oncol. 2019 Jun 22. pii: S0748-7983(19)30524.
    PubMed     Abstract available


  43. TU RH, Lin JX, Wang W, Li P, et al
    Pathological features and survival analysis of gastric cancer patients with positive surgical margins: A large multicenter cohort study.
    Eur J Surg Oncol. 2019 Jun 20. pii: S0748-7983(19)30520.
    PubMed     Abstract available


  44. CHENG J, Cai M, Shuai X, Gao J, et al
    Multimodal treatments for resectable gastric cancer: A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30504.
    PubMed     Abstract available


  45. FUJIYA K, Irino T, Furukawa K, Omori H, et al
    Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer.
    Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30497.
    PubMed     Abstract available


  46. RAWICZ-PRUSZYNSKI K, Mielko J, Cisel B, Skorzewska M, et al
    Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2019 Jun 3. pii: S0748-7983(19)30492.
    PubMed     Abstract available


    May 2019
  47. PAIELLA S, De Pastena M, Faustini F, Landoni L, et al
    Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases.
    Eur J Surg Oncol. 2019;45:788-792.
    PubMed     Abstract available


    April 2019
  48. CHEN QY, Zhong Q, Wang W, Desiderio J, et al
    Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study.
    Eur J Surg Oncol. 2019 Apr 9. pii: S0748-7983(19)30393.
    PubMed     Abstract available


  49. VAN PUTTEN M, Lemmens VEPP, van Laarhoven HWM, Pruijt HFM, et al
    Poor compliance with perioperative chemotherapy for resectable gastric cancer and its impact on survival.
    Eur J Surg Oncol. 2019 Apr 6. pii: S0748-7983(19)30385.
    PubMed     Abstract available


  50. RAMSINGH J, O'Dwyer P, Watson C
    Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland.
    Eur J Surg Oncol. 2019;45:631-634.
    PubMed     Abstract available


    March 2019
  51. HAO Y, Liu Y, Ishibashi H, Wakama S, et al
    Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Eur J Surg Oncol. 2019 Mar 9. pii: S0748-7983(19)30336.
    PubMed     Abstract available


  52. PATRAO AS, Papaxoinis G, Kordatou Z, Weaver JM, et al
    Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma.
    Eur J Surg Oncol. 2019;45:439-445.
    PubMed     Abstract available


  53. RAMOS MFKP, Pereira MA, Dias AR, Yagi OK, et al
    Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Eur J Surg Oncol. 2019;45:460-465.
    PubMed     Abstract available


  54. TOSOLINI C, Reim D, Schirren R, Feith M, et al
    Influence of the surgical technique on survival in the treatment of carcinomas of the true cardia (Siewert Type II) - Right thoracoabdominal vs. transhiatal-abdominal approach.
    Eur J Surg Oncol. 2019;45:416-424.
    PubMed     Abstract available


  55. GERTSEN EC, Brenkman HJF, Seesing MFJ, Goense L, et al
    Introduction of minimally invasive surgery for distal and total gastrectomy: a population-based study.
    Eur J Surg Oncol. 2019;45:403-409.
    PubMed     Abstract available


    January 2019
  56. XIONG B, Ma L, Huang W, Cheng Y, et al
    Efficiency of bursectomy in patients with resectable gastric cancer: An updated meta-analysis.
    Eur J Surg Oncol. 2019 Jan 21. pii: S0748-7983(19)30043.
    PubMed     Abstract available


  57. LIN JX, Lin JP, Xie JW, Wang JB, et al
    Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30002.
    PubMed     Abstract available


  58. BRENKMAN HJF, Cho M, Ruurda JP, Song K, et al
    European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry.
    Eur J Surg Oncol. 2019 Jan 2. pii: S0748-7983(19)30001.
    PubMed     Abstract available


    December 2018
  59. GRAZIOSI L, Marino E, Donini A
    Survival comparison in gastric cancer patients between 7th and 8th edition of the AJCC TNM staging system: The first western single center experience.
    Eur J Surg Oncol. 2018 Dec 21. pii: S0748-7983(18)32032.
    PubMed     Abstract available


  60. VAN DER VEEN A, Seesing MFJ, Wijnhoven BPL, de Steur WO, et al
    Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
    Eur J Surg Oncol. 2018;44:1955-1962.
    PubMed     Abstract available


    November 2018
  61. SALATI M, Valeri N, Spallanzani A, Braconi C, et al
    Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications.
    Eur J Surg Oncol. 2018 Nov 10. pii: S0748-7983(18)31997.
    PubMed     Abstract available


    October 2018
  62. WOHNRATH DR, Araujo RLC
    D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival.
    Eur J Surg Oncol. 2018 Oct 30. pii: S0748-7983(18)31984.
    PubMed     Abstract available


  63. JEONG O, Jung MR, Ryu SY
    Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.
    Eur J Surg Oncol. 2018 Oct 26. pii: S0748-7983(18)31934.
    PubMed     Abstract available


  64. CHEN H, Tang Z, Chen L, Li H, et al
    Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.
    Eur J Surg Oncol. 2018 Oct 20. pii: S0748-7983(18)31465.
    PubMed     Abstract available


  65. LUO Z, Zhou L, Balde AI, Li Z, et al
    Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: A multicenter propensity score analysis.
    Eur J Surg Oncol. 2018 Oct 19. pii: S0748-7983(18)31422.
    PubMed     Abstract available


  66. ZHAO B, Zhang J, Mei D, Luo R, et al
    Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31425.
    PubMed     Abstract available


  67. CLAASSEN YHM, Dikken JL, Hartgrink HH, de Steur WO, et al
    North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.
    Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31433.
    PubMed     Abstract available


  68. SISIC L, Blank S, Nienhuser H, Dorr S, et al
    Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
    Eur J Surg Oncol. 2018;44:1646-1656.
    PubMed     Abstract available


  69. CAO LL, Lu J, Lin JX, Zheng CH, et al
    Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Eur J Surg Oncol. 2018;44:1628-1633.
    PubMed     Abstract available


    August 2018
  70. PARK JY, Park KB, Kwon OK, Yu W, et al
    Comparison of laparoscopic proximal gastrectomy with double-tract reconstruction and laparoscopic total gastrectomy in terms of nutritional status or quality of life in early gastric cancer patients.
    Eur J Surg Oncol. 2018 Aug 30. pii: S0748-7983(18)31288.
    PubMed     Abstract available


  71. CHEN QY, Zheng CH, Li P, Xie JW, et al
    A long-term conditional survival analysis for gastric cancer based on 7th and 8th TNM classification in Eastern and Western populations.
    Eur J Surg Oncol. 2018 Aug 18. pii: S0748-7983(18)31278.
    PubMed     Abstract available


    July 2018
  72. RIHUETE CARO C, Manzanedo I, Pereira F, Carrion-Alvarez L, et al
    Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Eur J Surg Oncol. 2018 Jul 26. pii: S0748-7983(18)31189.
    PubMed     Abstract available


  73. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Abstract available


  74. NOWACKI M, Alyami M, Villeneuve L, Mercier F, et al
    Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Eur J Surg Oncol. 2018;44:991-996.
    PubMed     Abstract available


    June 2018
  75. HUANG SF, Chien TH, Fang WL, Wang F, et al
    The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease.
    Eur J Surg Oncol. 2018 Jun 11. pii: S0748-7983(18)31120.
    PubMed     Abstract available


  76. QUAN B, Yan WT, Yu JJ, Shen F, et al
    Relationship between complications and long-term prognosis after total gastrectomy with splenectomy for proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Jun 5. pii: S0748-7983(18)31077.
    PubMed    


    May 2018
  77. LIN JX, Lin JP, Li P, Xie JW, et al
    Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31068.
    PubMed     Abstract available


  78. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
    Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
    Eur J Surg Oncol. 2018;44:580-586.
    PubMed     Abstract available


  79. WHIBLEY J, Peters CJ, Halliday LJ, Chaudry AM, et al
    Poor performance in incremental shuttle walk and cardiopulmonary exercise testing predicts poor overall survival for patients undergoing esophago-gastric resection.
    Eur J Surg Oncol. 2018;44:594-599.
    PubMed     Abstract available


    March 2018
  80. CARMONA-BAYONAS A, Jimenez-Fonseca P, Echavarria I, Sanchez Canovas M, et al
    Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30988.
    PubMed     Abstract available


  81. MORGAGNI P, Solaini L, Saragoni L, Bencivenga M, et al
    An aggressive early gastric cancer: Kodama's PenA type.
    Eur J Surg Oncol. 2018 Mar 27. pii: S0748-7983(18)30985.
    PubMed     Abstract available


  82. WATANABE M, Kinoshita T, Tokunaga M, Kaito A, et al
    Complications and their correlation with prognosis in patients undergoing total gastrectomy with splenectomy for treatment of proximal advanced gastric cancer.
    Eur J Surg Oncol. 2018 Mar 23. pii: S0748-7983(18)30961.
    PubMed     Abstract available


  83. POLOM K, Boger C, Smyth E, Marrelli D, et al
    Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
    PubMed     Abstract available


    February 2018
  84. ALLUM W
    Essential requirements for quality cancer care - Oesophageal and gastric cancer.
    Eur J Surg Oncol. 2018 Feb 16. pii: S0748-7983(18)30668.
    PubMed    


  85. MIYAMOTO R, Inagawa S, Sano N, Tadano S, et al
    The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 13. pii: S0748-7983(18)30296.
    PubMed     Abstract available


  86. CLAASSEN YHM, Hartgrink HH, Dikken JL, de Steur WO, et al
    Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Eur J Surg Oncol. 2018 Feb 9. pii: S0748-7983(18)30297.
    PubMed     Abstract available


  87. WANG PL, Huang JY, Zhu Z, Gong BC, et al
    Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
    Eur J Surg Oncol. 2018 Feb 3. pii: S0748-7983(18)30289.
    PubMed     Abstract available


  88. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
    Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
    Eur J Surg Oncol. 2018;44:228-236.
    PubMed     Abstract available


    January 2018
  89. AGNES A, Lirosi MC, Panunzi S, Santocchi P, et al
    The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30014.
    PubMed     Abstract available


  90. SCHOUWENBURG MG, Busweiler LAD, Beck N, Henneman D, et al
    Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30035.
    PubMed     Abstract available


  91. VARAGUNAM M, Hardwick R, Riley S, Chadwick G, et al
    Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30008.
    PubMed     Abstract available


  92. HAGA Y, Hato S, Ikenaga M, Yamamoto K, et al
    Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer.
    Eur J Surg Oncol. 2018 Jan 11. pii: S0748-7983(18)30010.
    PubMed     Abstract available


    December 2017
  93. BECK N, Busweiler LAD, Schouwenburg MG, Fiocco M, et al
    Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study.
    Eur J Surg Oncol. 2017 Dec 13. pii: S0748-7983(17)31013.
    PubMed     Abstract available


    October 2017
  94. VISSER E, Brenkman HJF, Verhoeven RHA, Ruurda JP, et al
    Weekday of gastrectomy for cancer in relation to mortality and oncological outcomes - A Dutch population-based cohort study.
    Eur J Surg Oncol. 2017;43:1862-1868.
    PubMed     Abstract available


    September 2017
  95. AYUBI E, Safiri S
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery; methodological issues.
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30658.
    PubMed    


  96. LIN JX, Huang CM, Zheng CH, Li P, et al
    Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
    Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30694.
    PubMed     Abstract available


  97. POLOM K, Marrelli D, Pascale V, Ferrara F, et al
    The pattern of lymph node metastases in microsatellite unstable gastric cancer.
    Eur J Surg Oncol. 2017 Sep 14. pii: S0748-7983(17)30665.
    PubMed     Abstract available


  98. LU J, Zheng CH, Cao LL, Li P, et al
    The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 7th and 8th editions.
    Eur J Surg Oncol. 2017 Sep 13. pii: S0748-7983(17)30659.
    PubMed     Abstract available


  99. GALLEBERG RB, Knigge U, Tiensuu Janson E, Vestermark LW, et al
    Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Eur J Surg Oncol. 2017;43:1682-1689.
    PubMed     Abstract available


  100. TOMASELLO G, Petrelli F, Ghidini M, Pezzica E, et al
    Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.
    Eur J Surg Oncol. 2017;43:1607-1616.
    PubMed     Abstract available


    August 2017
  101. KATAOKA K, Deleersnijder A, Lordick F
    Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer?
    Eur J Surg Oncol. 2017 Aug 30. pii: S0748-7983(17)30644.
    PubMed     Abstract available


  102. RONELLENFITSCH U, Schwarzbach M, Hofheinz R, Kienle P, et al
    Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
    Eur J Surg Oncol. 2017;43:1550-1558.
    PubMed     Abstract available


    July 2017
  103. BUSWEILER LA, Henneman D, Dikken JL, Fiocco M, et al
    Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Eur J Surg Oncol. 2017 Jul 29. pii: S0748-7983(17)30589.
    PubMed     Abstract available


    June 2017
  104. HUBNER M, Grass F, Teixeira-Farinha H, Pache B, et al
    Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
    Eur J Surg Oncol. 2017;43:1102-1109.
    PubMed     Abstract available


    May 2017
  105. REIM D, Choi YS, Yoon HM, Park B, et al
    Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Eur J Surg Oncol. 2017 May 3. pii: S0748-7983(17)30447.
    PubMed     Abstract available


    April 2017
  106. MILONE M, Elmore U, Musella M, Parise P, et al
    Safety and efficacy of laparoscopic wedge gastrectomy for large gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2017;43:796-800.
    PubMed     Abstract available


  107. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    PubMed     Abstract available


    March 2017
  108. BOULIARIS K, Rachiotis G, Diamantis A, Christodoulidis G, et al
    Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
    Eur J Surg Oncol. 2017 Mar 27. pii: S0748-7983(17)30430.
    PubMed     Abstract available


  109. SASAKO M
    Is there role for laparoscopic gastrectomy for advanced gastric cancer.
    Eur J Surg Oncol. 2017 Mar 8. pii: S0748-7983(17)30363.
    PubMed    


  110. CHOI YY, Cheong JH
    Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Eur J Surg Oncol. 2017 Mar 1. pii: S0748-7983(17)30360.
    PubMed     Abstract available


    February 2017
  111. NORERO E, Vega EA, Diaz C, Cavada G, et al
    Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre.
    Eur J Surg Oncol. 2017 Feb 10. pii: S0748-7983(17)30050.
    PubMed     Abstract available


  112. CLIMENT M, Munarriz M, Blazeby JM, Dorcaratto D, et al
    Weight loss and quality of life in patients surviving 2 years after gastric cancer resection.
    Eur J Surg Oncol. 2017 Feb 9. pii: S0748-7983(17)30337.
    PubMed     Abstract available


  113. BOURAS G, Markar SR, Burns EM, Huddy JR, et al
    The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study.
    Eur J Surg Oncol. 2017;43:454-460.
    PubMed     Abstract available


    January 2017
  114. KAITO A, Kinoshita T, Shitara K, Shibasaki H, et al
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30058.
    PubMed     Abstract available


  115. LEHMANN K, Eshmuminov D, Bauerfeind P, Gubler C, et al
    18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Eur J Surg Oncol. 2017;43:196-202.
    PubMed     Abstract available


  116. KIM S, Paget-Bailly S, Messager M, Nguyen T, et al
    Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:218-225.
    PubMed     Abstract available


  117. PARRY K, van Rossum PS, Haj Mohammad N, Ruurda JP, et al
    The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Eur J Surg Oncol. 2017;43:226-233.
    PubMed     Abstract available


    December 2016
  118. TU RH, Lin JX, Zheng CH, Li P, et al
    Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2016 Dec 20. pii: S0748-7983(16)31052.
    PubMed     Abstract available


  119. PARK JM, Kim HI, Han SU, Yang HK, et al
    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
    Eur J Surg Oncol. 2016;42:1944-1949.
    PubMed     Abstract available


    October 2016
  120. XIE JW, Sun YQ, Feng CY, Zheng CH, et al
    Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
    Eur J Surg Oncol. 2016;42:1464-70.
    PubMed     Abstract available


  121. MOSQUERA C, Koutlas NJ, Fitzgerald TL
    Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Eur J Surg Oncol. 2016;42:1471-7.
    PubMed     Abstract available


    September 2016
  122. LEE JH, Kang JW, Nam BH, Cho GS, et al
    Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study.
    Eur J Surg Oncol. 2016 Sep 30. pii: S0748-7983(16)30895.
    PubMed     Abstract available


  123. LOU N, Chi CH, Chen XD, Zhou CJ, et al
    Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30894.
    PubMed     Abstract available


  124. MESSAGER M, de Steur W, Boelens PG, Jensen LS, et al
    Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Eur J Surg Oncol. 2016;42:1432-47.
    PubMed     Abstract available


    August 2016
  125. KIM JW, Choi SH
    Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30639.
    PubMed    


  126. CAPELLI L, Petracci E, Quagliuolo V, Saragoni L, et al
    Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Eur J Surg Oncol. 2016;42:1206-14.
    PubMed     Abstract available


  127. KULIG P, Sierzega M, Pach R, Kolodziejczyk P, et al
    Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Eur J Surg Oncol. 2016;42:1215-21.
    PubMed     Abstract available


  128. O'NEILL AC, Shinagare AB, Kurra V, Tirumani SH, et al
    Assessment of metastatic risk of gastric GIST based on treatment-naive CT features.
    Eur J Surg Oncol. 2016;42:1222-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: